Showing results (1-10 of 119) with videos related to
Sort By:
Pageof 12
Bioanalysis|July 25, 2017
Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effectAmedeo De Nicolò, Marco Cantù, Antonio D'AvolioAntiviral Research|July 25, 2025
Cerebrospinal fluid concentrations, viral suppression and biomarkers with long-acting cabotegravir and rilpivirine intramuscular injectionsAylin Yilmaz, Amedeo De Nicolò, Antonio D'Avolio, et al.Pharmaceutics|February 26, 2025
Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug-Drug InteractionsMartina Billi, Sara Soloperto, Stefano Bonora, et al.Journal of Pharmaceutical and Biomedical Analysis|January 5, 2019
LC-MS application for therapeutic drug monitoring in alternative matricesValeria Avataneo, Antonio D'Avolio, Jessica Cusato, et al.Pharmacogenomics|December 6, 2017
Precision medicine for HIV: where are we?Jessica Cusato, Sarah Allegra, Amedeo De Nicolò, et al.Pharmacogenomics|June 2, 2016
Pharmacogenetics of ribavirin-induced anemia in HCV patientsAntonio D'Avolio, Jessica Cusato, Amedeo De Nicolò, et al.Molecules (Basel, Switzerland)|February 15, 2022
Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from "Integriamoci", a Pilot Pharmacokinetic StudyValeria Avataneo, Alice Palermiti, Amedeo De Nicolò, et al.Journal of Medical Virology|August 19, 2014
Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and ELucio Boglione, Chiara Simona Cardellino, Amedeo De Nicolò, et al.Journal of Pharmaceutical and Biomedical Analysis|June 4, 2015
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patientsAmedeo De Nicolò, Marco Simiele, Debora Pensi, et al.International Journal of Antimicrobial Agents|July 23, 2016
Entecavir plasma concentrations are inversely related to HBV-DNA decrease in a cohort of treatment-naïve patients with chronic hepatitis BLucio Boglione, Amedeo De Nicolò, Jessica Cusato, et al.Pageof 12